University of Oxford and Oracle Cloud System helped researchers identify COVID-19 variants faster
On Sept. 20, 2021, the University of Oxford and Oracle’s Global Pathogen Analysis System announced that it was…
-
-
CDC to invest $2.1 billion to protect patients and healthcare workers from COVID-19 and future infectious diseases
On Sept. 17, 2021, the Biden-Harris Administration announced a $2.1 billion investment to improve infection prevention and control…
-
The COVID-19 pandemic caused the biggest decrease in life expectancy since World War II
On Sept. 17, 2021, Oxford’s Leverhulme Centre for Demographic Science reported the COVID-19 pandemic triggered life expectancy losses…
-
Great cats tested presumptive positive for COVID-19 at the Smithsonian’s National Zoo
On Sept. 17, 2021, six African lions, a Sumatran tiger and two Amur tigers tested presumptive positive at…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | USDA | Vaccine | Veterinary
Zoo Atlanta reported nine western lowland gorillas tested positive for COVID-19
On Sept. 17, 2021, Zoo Atlanta reported that of the 20 gorillas at the Zoo, 18 showed clinical…
-
US Department of Defense awarded $647 million in contracts for over-the-counter COVID-19 test kits
On Sept. 17, 2021, the Department of Defense (DOD), in coordination with the Department of Health and Human…
-
Africa faced 470 million COVID-19 vaccine shortfall in 2021
On Sept. 16, 2021, as the COVAX Facility is forced to slash planned COVID-19 vaccine deliveries to Africa…
-
Moderna announces Health Canada approves its COVID-19 vaccine
On Sept. 16, 2021, Moderna announced Health Canada had approved the New Drug Submission (NDS-CV) for SPIKEVAX (elasomeran…
-
Novavax included in University of Oxford Com-COV3 study comparing mixed COVID-19 vaccine in adolescents
On Sept. 16, 2021, Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing…
-
Celsion and Hainan Poly Pharm signed agreement to manufacture Celsion’s DNA-based vaccine
On Sept. 16, 2021, Celsion and Hainan Poly Pharm announced an amendment to their existing contract manufacturing agreement…
-
Biotechnology | Clinical Research | COVID-19 | Infectious Disease | NIH | Non-Profit Research | Therapeutics
NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
-
Guinea declared end of Marburg virus disease outbreak
On Sept. 15, 2021, Guinea declared the end of the Marburg virus disease outbreak having recorded no new…
-
Oragenics initiated COVID-19 challenge study evaluating multiple formulations of its SARS-CoV-2 vaccine candidate
On Sept. 15, 2021, Oragenics announced the initiation of a study to evaluate the immunogenicity and viral load…
-
Biotechnology | COVID-19 | Diagnostics | FDA
InBios received FDA EUA for COVID-19 IgG antibody rapid test
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
-
Emergent BioSolutions announced manufacturing agreement with Providence Therapeutics for mRNA COVID-19 vaccine candidate
On Sept. 14, 2021, Emergent BioSolutions and Providence Therapeutics announced they have entered into a five-year contract development…
-
Twist Bioscience committed to deliver synthetic RNA controls to fight Delta plus variants of COVID-19
On Sept. 14, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
-
Regeneron announced U.S. Government agreement to purchase additional REGEN-COV antibody cocktail
On Sept. 14, 2021, Regeneron announced an agreement with the U.S. Department of Health and Human Services and…
-
City of Hope trial was first to test an investigational COVID-19 vaccine in immunocompromised bone marrow transplant
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
-
US Department of Defense awarded $3.2 billion in contract modifications for monoclonal antibodies
On Sept. 14, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
World global health leaders made urgent call to accelerate vaccination globally
On Sept. 14, 2021, the World Health Organization (WHO) Director General Dr. Tedros Adhanom Ghebreyesus and a group…
-
Misdirected antibodies linked to severe COVID-19
On Sept. 14, 2021, the National Institutes of Health (NIH) announced that an international project called the COVID…
-
Twist Bioscience collaborates with Adicet Bio to accelerate discovery of Gamma Delta T cell cancer therapeutics
On Sept. 13, 2021, Twist Bioscience announced and Adicet Bio announced a collaboration to accelerate the discovery of…
-
Atlanta Zoo’s western lowland gorillas tested presumptive positive for COVID-19
On Sept. 10, 2021, Zoo Atlanta reported that it had received presumptive positive test results indicating that members…
-
US Department of Defense awarded $35.8 million contract to Mettler-Toledo Rainin to increase domestic production capacity of pipette tips
On Sept. 10, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
-
Biotechnology | Genomics | NIH | Therapeutics
NIH provided $185 million for research to advance understanding of how human genome functions
On Sept. 9, 2021, the National Institutes of Health (NIH) announced that it was providing approximately $185 million…
-
2022 Breakthrough Prize in Life Sciences awarded to Penn Medicine mRNA pioneers Drew Weissman and Katalin Karik
On Sept. 9, 2021, the University of Pennsylvania announced that the Breakthrough Prize in Life Sciences was awarded…
-
AIM ImmunoTech submitted pre-IND application to FDA for phase 2 clinical study of Ampligen for post-COVID-19 cognitive dysfunction
On Sept. 8, 2021, AIM ImmunoTech announced that is had submitted a Pre-Investigational New Drug application (Pre-IND) to…
-
Novavax initiated phase 1/2 clinical trial of combination vaccine for COVID-19 and seasonal influenza
On Sept. 8, 2021, Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate…
-
Bio-Techne and Carterra initiated clinical research collaboration for COVID-19 variant analysis
On Sept. 8, 2021, Bio-Techne and Carterra announced a clinical research collaboration studying COVID-19 variants. To assess immune…
-
Resilience to manufacture mRNA for Moderna’s COVID-19 vaccine
On Sept. 8, 2021, National Resilience, a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem,…
